SKI Market

A+| A| A-|

Indian Indices

Sensex

77,155.62 347.14
( 0.45%)

Global Indices

Nasdaq

52,022.73 330.70
(0.64%)

Dow Jones

7,531.82 -43.47
(-0.57%)

Hang Seng

69,975.80 571.30
(0.82%)

Nikkei 225

10,504.45 73.83
(0.71%)

Forex

USD-INR

94.63 -0.29
(-0.31%)

EUR-INR

109.79 -0.04
(-0.03%)

GBP-INR

127.09 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

143.94

432036.25

EPS(TTM)

Face Value()

Div & Yield %

12.51

0.89

Back

Sambandam Spinning Mills reports consolidated net loss of Rs 2.96 crore in the March 2026 quarter

May 25,2026

Net loss of Sambandam Spinning Mills reported to Rs 2.96 crore in the quarter ended March 2026 as against net profit of Rs 0.20 crore during the previous quarter ended March 2025. Sales rose 3.88% to Rs 67.93 crore in the quarter ended March 2026 as against Rs 65.39 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 5.67 crore in the year ended March 2026 as against net loss of Rs 7.35 crore during the previous year ended March 2025. Sales declined 1.80% to Rs 263.66 crore in the year ended March 2026 as against Rs 268.48 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	67.93	65.39	4	263.66	268.48	-2
OPM %	0.88	6.99	-	4.37	3.46	-
PBDT	-1.53	2.20	PL	1.48	-1.03	LP
PBT	-3.72	0.26	PL	-7.39	-10.48	29
NP	-2.96	0.20	PL	-5.67	-7.35	23

77,155.62 347.14 ( 0.45%)

52,022.73 330.70 (0.64%)

7,531.82 -43.47 (-0.57%)

69,975.80 571.30 (0.82%)

10,504.45 73.83 (0.71%)

94.63 -0.29 (-0.31%)

109.79 -0.04 (-0.03%)

127.09 -0.16 (-0.13%)

0.59 0.00 (-0.29%)